Takeabreak2020-08-25 21:55
$万基遗传(MYGN)$ 今年至今跌去30%+的还有$Adma生物制品(ADMA)$, $BioDelivery科学国际(BDSI)$, CRVS查看全文
chuminhua2020-05-23 23:21
5/20,FDA批准了Foundation Medicine和Myriad Genetics$万基遗传(MYGN)$ 的伴随诊断测试,用于AZ和MSD的PARP抑制剂Lynparza(olaparib),用于筛选出适合治疗的转移性去势抵抗性前列腺癌患者。查看全文
网络异常请稍后再试2020-05-12 07:12
$万基遗传(MYGN)$
2019/8/13盘后财报,MISS,8/14号暴跌43%
2019/11/4盘后财报,MISS,11/5号暴跌40%;
2020/2/6盘后财报,MISS,2/7号暴跌30%;
2020/5/5盘后财报,MISS,5/6号跌4%;
这股真是有个性啊。。。。。。查看全文
$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001517026-22-000004 Size: 4 KB 网页链接
$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-011943 Size: 4 KB 网页链接
$万基遗传(MYGN)$ 内部交易: 2022-02-28,Chief People Officer,Hart Jayne B. ,卖出,10500普通股, $25.00
$万基遗传(MYGN)$ 内部交易: 2022-02-28,Chief People Officer,Hart Jayne B. ,期权,10500普通股, $23.98
$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001519749-22-000004 Size: 13 KB 网页链接
$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001843872-22-000004 Size: 4 KB 网页链接
$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001843568-22-000002 Size: 5 KB 网页链接
$万基遗传(MYGN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000899923-22-000033 Act: 34 Size: 13 MB 网页链接
$万基遗传(MYGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000899923-22-000022 Act: 34 Size: 665 KB 网页链接
$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001621899-22-000002 Size: 6 KB 网页链接